Filings Intelligence
Company filings profile · CIK 0001763950

Lantern Pharma Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for Lantern Pharma Inc. (LTRN): 7 filings in the last 90 days vs 18 in the prior 90 (filing-velocity cooling ↓ · 0.39×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 24, 2026. Source-linked, daily-refreshed.

Material 8-K events — Lantern Pharma Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 24, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Sep 23, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Aug 14, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits↗
Aug 3, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Jun 2, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
May 15, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
May 14, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits↗
Apr 10, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Mar 30, 2026Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits↗
Jan 23, 2026Regulation FD Disclosure; Financial Statements and Exhibits↗
Nov 13, 2025Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits↗
Sep 23, 2025Item 5.07↗

Watch Lantern Pharma Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Watch this company →See a sample alert

Insider transactions (Form 4 / 3 / 5)

FiledForm
May 14, 20264↗
May 14, 20264↗
Jan 13, 20264↗
Jan 13, 20264↗
Jan 13, 20264↗
Jan 13, 20264↗
Jan 13, 20264↗
Dec 22, 20254↗
Dec 22, 20254↗
Sep 23, 20254↗
Sep 23, 20254↗
Sep 23, 20254↗
Sep 23, 20254↗
Sep 23, 20254↗
Sep 23, 20254↗
Aug 20, 20254↗
Jul 30, 20253↗
Jun 13, 20254↗
Jun 13, 20254↗
Jun 13, 20254↗

Recent filings

FiledFormDetail
Sep 24, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Sep 23, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 14, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits ↗
Aug 14, 202610-Q 10-Q ↗
Aug 4, 2026SCHEDULE 13G ↗
Aug 3, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jul 23, 2026SCHEDULE 13G/A ↗
Jun 18, 2026EFFECT Item ; Item ; Item ↗
Jun 12, 2026S-1 S-1 ↗
Jun 2, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
May 21, 2026D Item 06b ↗
May 15, 2026SCHEDULE 13D/A ↗
May 15, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
May 15, 202610-Q 10-Q ↗
May 14, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits ↗
May 14, 20264 4 ↗
May 14, 20264 4 ↗
May 14, 2026424B5 424B5 ↗
Apr 30, 202610-K/A 10-K/A ↗
Apr 16, 2026SCHEDULE 13D/A ↗
Apr 10, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Apr 3, 2026SCHEDULE 13G ↗
Mar 30, 2026424B5 424B5 ↗
Mar 30, 202610-K 10-K ↗
Mar 30, 20268-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits ↗
Feb 23, 2026SCHEDULE 13D/A ↗
Jan 23, 20268-K Regulation FD Disclosure; Financial Statements and Exhibits ↗
Jan 13, 20264 4 ↗
Jan 13, 20264 4 ↗
Jan 13, 20264 4 ↗
Jan 13, 20264 4 ↗
Jan 13, 20264 4 ↗
Dec 22, 20254 4 ↗
Dec 22, 20254 ↗
Nov 13, 20258-K Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits ↗
Nov 12, 202510-Q 10-Q ↗
Sep 23, 20258-K Item 5.07 ↗
Sep 23, 20254 4 ↗
Sep 23, 20254 4 ↗
Sep 23, 20254 4 ↗